Key Insights from Attending ASH 2025
Dr. Lore Gruenbaum shares key insights from the 67th ASH Annual Meeting, covering advancements in multiple myeloma, AML, CLL, and cell therapy. The discussion also touches on the application of artificial intelligence in accelerating precision medicine, referencing the Blood…